Tennessee Valley Asset Management Partners Makes New $50,000 Investment in UiPath Inc. (NYSE:PATH)

Tennessee Valley Asset Management Partners bought a new position in shares of UiPath Inc. (NYSE:PATH) during the fourth quarter, HoldingsChannel reports. The fund bought 2,000 shares of the healthcare company’s stock, valued at approximately $50,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Vanguard Group Inc. grew its stake in shares of UiPath by 7.6% in the third quarter. Vanguard Group Inc. now owns 37,750,773 shares of the healthcare company’s stock worth $645,916,000 after purchasing an additional 2,673,718 shares during the last quarter. FMR LLC grew its stake in shares of UiPath by 2.9% in the third quarter. FMR LLC now owns 16,238,176 shares of the healthcare company’s stock worth $277,835,000 after purchasing an additional 463,032 shares during the last quarter. Senvest Management LLC grew its stake in shares of UiPath by 3.0% in the third quarter. Senvest Management LLC now owns 6,209,655 shares of the healthcare company’s stock worth $106,247,000 after purchasing an additional 181,722 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of UiPath by 2.3% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,301,413 shares of the healthcare company’s stock worth $131,687,000 after purchasing an additional 119,782 shares during the last quarter. Finally, Northern Trust Corp lifted its holdings in UiPath by 10.4% in the third quarter. Northern Trust Corp now owns 2,467,710 shares of the healthcare company’s stock valued at $42,223,000 after buying an additional 233,362 shares during the period. Institutional investors own 62.50% of the company’s stock.

Insider Buying and Selling

In related news, CFO Ashim Gupta sold 16,000 shares of the firm’s stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $22.84, for a total value of $365,440.00. Following the completion of the transaction, the chief financial officer now directly owns 87,505 shares of the company’s stock, valued at approximately $1,998,614.20. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In the last ninety days, insiders sold 72,000 shares of company stock valued at $1,591,360. Company insiders own 31.03% of the company’s stock.

UiPath Stock Up 3.4 %

UiPath stock opened at $19.54 on Wednesday. UiPath Inc. has a twelve month low of $12.38 and a twelve month high of $27.87. The firm has a 50 day moving average price of $22.55 and a 200-day moving average price of $21.56. The company has a market capitalization of $11.12 billion, a P/E ratio of -114.94 and a beta of 0.96.

UiPath (NYSE:PATH) last released its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.10. The company had revenue of $405.25 million during the quarter, compared to the consensus estimate of $383.32 million. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. Equities analysts expect that UiPath Inc. will post -0.04 EPS for the current fiscal year.

Analysts Set New Price Targets

PATH has been the topic of several recent analyst reports. Canaccord Genuity Group boosted their target price on shares of UiPath from $27.00 to $30.00 and gave the company a “buy” rating in a report on Friday, March 15th. TD Cowen upped their price objective on shares of UiPath from $25.00 to $28.00 and gave the stock an “outperform” rating in a research report on Thursday, March 14th. BMO Capital Markets upped their price objective on shares of UiPath from $24.00 to $28.00 and gave the stock a “market perform” rating in a research report on Thursday, March 14th. Wells Fargo & Company upped their price objective on shares of UiPath from $24.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Thursday, March 14th. Finally, Scotiabank upped their price objective on shares of UiPath from $29.00 to $30.00 and gave the stock a “sector perform” rating in a research report on Thursday, March 14th. Nine research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $27.41.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.